Artiva Biotherapeutics, Inc.(ARTV)
$3.96-0.11 (-2.70%)
ARTV
Artiva Biotherapeutics, Inc. financials statements
$3.96
At close:-0.11 (-2.70%)
Want to see ARTV full AI Analyst Report?
Artiva Biotherapeutics, Inc. (ARTV) Income Statement
495 Followers
Artiva Biotherapeutics, Inc. Income Statement
Last quarter (Q3 2026), Artiva Biotherapeutics, Inc.'s total revenue was $0.00. In Q3, Artiva Biotherapeutics, Inc.'s net income was $-28.82M. See Artiva Biotherapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 251.00K | $ 33.49M | $ 4.93M | $ 2.00M | |
| $ -2.60M | $ 251.00K | $ 33.49M | $ 4.93M | $ 2.00M | |
| $ 88.01M | $ 67.53M | $ 64.16M | $ 64.76M | $ 55.27M | |
| Depreciation and Amortization | $ 2.60M | $ 2.43M | $ 2.27M | $ 1.16M | $ 248.00K |
| $ -81.27M | $ -56.06M | $ -25.36M | $ -57.18M | $ -71.58M | |
| $ -90.61M | $ -67.28M | $ -30.67M | $ -59.83M | $ -53.27M | |
| $ 6.75M | $ 8.79M | $ 3.05M | $ 1.49M | $ -18.55M | |
| $ -83.86M | $ -58.49M | $ -27.62M | $ -58.34M | $ -71.83M | |
| $ -83.86M | $ -58.49M | $ -27.70M | $ -58.39M | $ -71.83M | |
| Per Share Metrics | |||||
| Basic EPS | $ -3.43 | $ -5.20 | $ -1.19 | $ -3.32 | $ -4.08 |
| Diluted EPS | $ -3.43 | $ -5.20 | $ -1.19 | $ -3.32 | $ -4.08 |
| Weighted Average Shares Outstanding | 24.44M | 24.36M | 23.28M | 17.58M | 17.58M |
| Weighted Average Shares Outstanding (Diluted) | 24.44M | 24.36M | 23.28M | 17.58M | 17.58M |
Currency in USD
